DIA Biosimilars 2013

Technology Solutions

Life Technologies launches EZQC Online

Monday, September 30, 2013 02:46 PM

Life Technologies, a global biotechnology company, has launched EZQC Online, a web-based tool for quality control management in molecular diagnostic labs. EZQC Online contains three modules: a guidance tool for initial validation and verification of molecular tests, a tool to help labs meet CLIA standards for calibration verifications and a tool for ongoing quality control monitoring that provides an opportunity for peer-to-peer comparisons.

More... »

Cenduit: Now with Patient Reminders

Pacific Biosciences, Roche ink agreement for clinical diagnostics

Friday, September 27, 2013 10:43 AM

Pacific Biosciences of California, provider of the PacBio RS II DNA Sequencing System, has entered into an agreement with Roche Diagnostics to develop diagnostic products, including sequencing systems and consumables, based on Pacific Biosciences' Single Molecule, Real-Time (SMRT) technology.

More... »

CRF Health – eCOA Forum

Gentris, BioFortis partner

Wednesday, September 25, 2013 03:14 PM

Gentris, a global provider of pharmacogenomics and biorepository solutions, has partnered with BioFortis to integrate its Labmatrix and Qiagram software into Gentris' laboratory operations. The Labmatrix and Qiagram software will provide an advanced platform for clients to view and manage samples housed in the Gentris biorepository, while simultaneously enhancing their ability to collect, harmonize and integrate multiple data sources, including clinical, molecular, patient and biospecimen data.

More... »

Almac launches SupplyTraQ technology solution

Wednesday, September 25, 2013 03:13 PM

Almac has launched SupplyTraQ, a web-based drug accountability and reconciliation tool that improves clinical trial drug supply management and simplifies post-trial administration. Compatible with IXRS, the company’s IVR/IWR technology, SupplyTraQ enables users to capture drug supply data in real-time and improve the accuracy of the supply management process. 

More... »

Wolters Kluwer Health launches Lippincott mobile nursing app

Wednesday, September 25, 2013 12:37 PM

Wolters Kluwer Health, a global provider of information and point-of-care solutions, has launched the Lippincott’s Nursing Advisor app, the first mobile application of an online clinical decision support solution for nurses. 

More... »

NCCN, McKesson Specialty Health, U.S. Oncology Network integrate with Elekta, Varian

Wednesday, September 25, 2013 12:26 PM

The National Comprehensive Cancer Network (NCCN), The U.S. Oncology Network and McKesson Specialty Health have inked agreements to provide future integration with Elekta and Varian that will enhance the ability to provide cancer patients with evidence-based quality care. The two oncology information systems are Elekta’s MOSAIQ and Varian’s ARIA.

More... »

BioTime, Jade Therapeutics ink deal

Friday, September 20, 2013 10:52 AM

BioTime, a biotechnology company that develops and markets products in regenerative medicine, has signed an exclusive sublicense agreement with Jade Therapeutics, a Salt Lake City, Utah-based developer of ophthalmic sustained-release drug delivery platforms. This new agreement supersedes the previously announced sublicense and supply agreements and expands the licensed field of use to include certain additional uses, such as BioTime’s HyStem hydrogel technology for the delivery of all potential therapeutic molecules to the human eye. Excluded from the licensed field of use is the HyStem technology for the delivery of cells with or without any molecules necessary for the therapeutic benefit of those cells, for use in making punctal plugs, for diagnostic and research reagents and for non-human applications.

More... »

Trifecta Clinical, SAFE-BioPharma partner

Friday, September 20, 2013 10:37 AM

Trifecta Clinical, a global clinical technology solutions provider, has partnered with SAFE-BioPharma to implement the SAFE-BioPharma digital identity and signature standard across its application platforms. The digital identity and signature standard provides standardized, high-assurance identity trust for cyber-transactions across the biopharmaceutical and healthcare sectors. This will accelerate the adoption of standards-based identity management, enhancing security, quality and compliance. The company also joined SAFE-BioPharma Association’s Vendor Partner Program.

More... »

AstraZeneca, Daiichi Sankyo launch reflux esophagitis iPhone app

Wednesday, September 18, 2013 01:36 PM

Daiichi Sankyo and AstraZeneca are working to educate the public about reflux esophagitis through a campaign entitled Do you experience heartburn or acid reflux? The awareness building effort seeks to ensure an accurate understanding of the symptoms of reflux esophagitis and how they affect the daily lives of patients. The campaign incorporates a variety of media, featuring TV commercials, an iPhone app and a website to encourage patients to seek the appropriate treatment and take control of their lives.

More... »

IRB Services selects Intralinks VIA

Wednesday, September 18, 2013 10:47 AM

IRB Services (Institutional Review Board Services), a global provider of research ethics review and related services for the clinical research and behavioral science industries, has selected Intralinks VIA to support all of its secure beyond the firewall collaboration needs. Intralinks is a global SaaS provider of inter-enterprise content management and collaboration solutions.

More... »

CenterWatch
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs